Rituximab impacts on HBV reactivation in the therapy of non-Hodgkin's lymphoma

Hui-Hua Hsiao

Presentation information

Oral Session

Oral Session 3-7C Malignant Lymphoma: Advese events/Others

Sun. Oct 14, 2018 1:50 PM - 2:50 PM No.7 (Osaka International Convention Center, 10F 1001)

Chair: Koji Kato (Kyushu University Hospital Hematology, Oncology& Cardiovascular Medicine, Japan)

【Ｅ】

[OS3-7C-5] Rituximab impacts on HBV reactivation in the therapy of non-Hodgkin's lymphoma

Hui-Hua Hsiao¹, Yu-Fen Tsai¹, Jeng-Shiun Du¹, Ming-Hui Lin¹, Shih-Hao Tang¹, Hui-Ching Wang¹, Shih-Feng Cho^1,2, Chiung-Tang Huang¹, Jui-Feng Hsu¹, Yi-Chang Liu^1,2, Samuel Y Hsiao¹, Chia-Yen Dai^1,2, Ming-Lung Yu^1,2, Ta-Chih Liu^1,2 (1.Internal Medicine Department, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, 2.Faculty of Medicine, Kaohiung Medical University, Kaohsiung, Taiwan)

Abstract password authentication.
Password is written on a program and abstract book.